Incyte (INCY) Stock Forecast & Price Target
Score
Incyte Corporation price target
| INCY | |
|---|---|
| Low | $104.00 |
| Average | $137.67 |
| High | $157.00 |
| Upside vs current price | +12.6% |
The average target of $137.67 is +12.6% versus the current INCY price of $122.27.
Incyte Corporation analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 2 |
| Buy | 11 |
| Hold | 14 |
| Sell | 1 |
| Strong sell | 1 |
| Consensus | Hold |
29 analysts cover INCY.
Incyte Corporation EPS and revenue estimates
The estimate table for the Incyte Corporation keeps 2026 EPS $3.21, 2027 EPS $8.16, and years with fewer than three analysts are not filled in.
| Fiscal year | EPS estimate | Revenue estimate |
|---|---|---|
| 2026 | $3.21 | $6.03B |
| 2027 | $8.16 | $6.27B |
Is Incyte Corporation a buy or sell?
Of the 29 analysts covering Incyte Corporation, 13 rate it a buy (2 strong buy and 11 buy), 14 rate it a hold, and 2 rate it a sell (1 sell and 1 strong sell).
The INCY consensus label is Hold, beside 13 buy-side ratings and 2 sell-side ratings.
The average target of $137.67 implies +12.6% versus the current price of $122.27.
the Incyte Corporation closes with 13 buy-side ratings and 2 on the sell side. The headcount is Hold.
Reading the Incyte Corporation forecast
Between the INCY low of $104.00 and the high of $157.00, the average target is $137.67.
From today's $122.27 print, the INCY average target is +12.6% away.
Buy and the rest of the scale both have a real share of INCY: 13 of 29 analysts are on the buy side, 14 are at hold, and 2 are on the sell side, and the published consensus is Hold.
INCY has both upgrades (1) and downgrades (0) in the recent window.
INCY targets have not moved much: $139.13 recently, $137.58 across the quarter.
Coverage of INCY is broad at 29 analysts, and the average is a crowd rather than a single desk.
Incyte Corporation forecast questions
What is the INCY price target?
The published range for INCY is $104.00 to $157.00, with an average of $137.67. That average is +12.6% versus the current price of $122.27.
Is Incyte Corporation a buy or sell?
Of the 29 analysts covering Incyte Corporation, 13 rate it a buy, 14 rate it a hold, and 2 rate it a sell. The consensus is Hold, which for INCY is 13 on the buy side, 14 at hold, and 2 on the sell side.
What is the EPS estimate for Incyte Corporation?
Analyst EPS estimates for Incyte Corporation: 2026 $3.21, 2027 $8.16.
What is the revenue estimate for Incyte Corporation?
Analyst revenue estimates for Incyte Corporation: 2026 $6.03B, 2027 $6.27B.
How many analysts cover INCY?
29 analysts cover INCY. Their consensus on INCY is Hold, across those 29.